SBI Mutual Fund and Aditya Birla Sun Life Mutual Fund on Thursday bought shares of drug firm Alkem Laboratories Ltd worth around Rs 538 crore through open market transactions.
According to data available with the National Stock Exchange (NSE), SBI Mutual Fund bought 24 lakh shares and Aditya Birla Sun Life MF purchased 7.5 lakh shares of the pharmaceutical company for Rs 1,708.45 apiece.
While SBI MF bought the shares for Rs 410.02 crore, Aditya Birla acquired scrips for Rs 128.13 crore.
In a separate transaction, Prasid Uno Family Trust sold 36 lakh shares of Alkem for Rs 1,708.45 per scrip.
According to the shareholding pattern available on the NSE, Prasid Uno held over 41 lakh shares or 3.43 per cent stake in Alkem at the end of the June 2019 quarter.
Shares of Alkem Laboratories ended at Rs 1,742 on the NSE, down 0.19 per cent from the previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app